The Use of Psilocybin in the Treatment of Psychiatric Disorders with Attention to Relative Safety Profile: A Systematic Review

The experimental effects of psilocybin on symptoms of anxiety and depression: A meta-analysis

(2020) Simon B. Goldberg et al.   PSYCHIATRY RESEARCH

Perceived outcomes of psychedelic microdosing as self-managed therapies for mental and substance use disorders

(2020) Toby Lea et al.   PSYCHOPHARMACOLOGY

Depression, Mindfulness, and Psilocybin: Possible Complementary Effects of Mindfulness Meditation and Psilocybin in the Treatment of Depression. A Review

(2020) Kristin Heuschkel et al.   Frontiers in Psychiatry

PUBLIC MENTAL HEALTH IN POST-COVID-19 ERA

(2020) Fei-Fei Ren et al.   Psychiatria Danubina

Psilocybin as a New Approach to Treat Depression and Anxiety in the Context of Life-Threatening Diseases—A Systematic Review and Meta-Analysis of Clinical Trials

(2020) Ana Sofia Vargas et al.   Biomedicines

MDMA-assisted psychotherapy for treatment of anxiety and other psychological distress related to life-threatening illnesses: a randomized pilot study

(2020) Philip E. Wolfson et al.   Scientific Reports

Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder

(2020) Alan K. Davis et al.   JAMA Psychiatry

Depression

(2018) Gin S Malhi et al.   LANCET

Neuropharmacology of N,N-dimethyltryptamine

(2016) Theresa M. Carbonaro et al.   BRAIN RESEARCH BULLETIN

Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial

(2016) Roland R Griffiths et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial

(2016) Stephen Ross et al.   JOURNAL OF PSYCHOPHARMACOLOGY

The Economic Burden of Adults With Major Depressive Disorder in the United States (2005 and 2010)

(2015) Paul E. Greenberg et al.   JOURNAL OF CLINICAL PSYCHIATRY

Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study

(2015) Michael P Bogenschutz et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction

(2014) Matthew W Johnson et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Clinical Practice Guideline: The Diagnosis, Management, and Prevention of Bronchiolitis

(2014) S. L. Ralston et al.   PEDIATRICS

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

(2013) David Moher   ANNALS OF INTERNAL MEDICINE

The Epidemiology of Depression and the Evolution of Treatment

(2012) Robert M. A. Hirschfeld   JOURNAL OF CLINICAL PSYCHIATRY

A randomized, controlled pilot study of MDMA (±3,4-Methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic Post-Traumatic Stress Disorder (PTSD)

(2012) Peter Oehen et al.   JOURNAL OF PSYCHOPHARMACOLOGY

The determination and interpretation of the therapeutic index in drug development

(2012) Patrick Y. Muller et al.   NATURE REVIEWS DRUG DISCOVERY

Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies

(2011) Alex J Mitchell et al.   LANCET ONCOLOGY

Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer

(2010) Charles S. Grob et al.   ARCHIVES OF GENERAL PSYCHIATRY

Hallucinogenic Mushrooms in Mexico: An Overview

(2010) Gastón Guzmán   ECONOMIC BOTANY

Identifying HAM-A cutoffs for mild, moderate, and severe generalized anxiety disorder

(2010) Louis S. Matza et al.   INTERNATIONAL JOURNAL OF METHODS IN PSYCHIATRIC RESEARCH

The Pharmacology of Lysergic Acid Diethylamide: A Review

(2008) Torsten Passie et al.   CNS Neuroscience & Therapeutics